Eric A. Shikatani

2.4k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

Eric A. Shikatani is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Eric A. Shikatani has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Eric A. Shikatani's work include Diabetes Treatment and Management (3 papers), Congenital heart defects research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Eric A. Shikatani is often cited by papers focused on Diabetes Treatment and Management (3 papers), Congenital heart defects research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Eric A. Shikatani collaborates with scholars based in Canada, United States and Switzerland. Eric A. Shikatani's co-authors include Mansoor Husain, Ralph Weissleder, Clinton S. Robbins, Matthias Nahrendorf, Georg F. Weber, Rostic Gorbatov, Maddy Parsons, Filip K. Świrski, Galina K. Sukhova and Caleb C. J. Zavitz and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Eric A. Shikatani

13 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

2013 779 citations Clinton S. Robbins, Ingo Hilgendorf et al. Nature Medicine profile →

Peers

Eric A. Shikatani

IMMUN

MB

EDM

EPIDE

SURGE

Elyce Ozols Australia

Sophie Colin France

Marie Sanson United States

J. H. Qiao United States

Takafumi Senokuchi Japan

Nirav Dhanesha United States

Bruno Poirier France

Adrián Recinos United States

Bernd Hewing Germany

Hong Pei United States

Elyce Ozols Australia

Eric A. Shikatani

436 ×0.7

IMMUN

534 ×0.9

MB

256 ×0.8

EDM

213 ×0.8

EPIDE

208 ×0.8

SURGE

Citations per year, relative to Eric A. Shikatani Eric A. Shikatani (= 1×) peers Elyce Ozols

Countries citing papers authored by Eric A. Shikatani

Since Specialization

Citations

This map shows the geographic impact of Eric A. Shikatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Shikatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Shikatani more than expected).

Fields of papers citing papers by Eric A. Shikatani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Shikatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Shikatani. The network helps show where Eric A. Shikatani may publish in the future.

Co-authorship network of co-authors of Eric A. Shikatani

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Shikatani. A scholar is included among the top collaborators of Eric A. Shikatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Shikatani. Eric A. Shikatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Chen, Wentao, Jian Luo, Wei Liu, et al.. (2021). The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism. The Journal of Immunology. 206(11). 2714–2724. 11 indexed citations

2.

Siraj, M. Ahsan, Sanja Beca, Abdul Momen, et al.. (2020). Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α. Journal of Clinical Investigation. 130(3). 1392–1404. 61 indexed citations

3.

Shikatani, Eric A., Rickvinder Besla, Andrew Levy, et al.. (2019). B-Cell Deficiency Lowers Blood Pressure in Mice. Hypertension. 73(3). 561–570. 27 indexed citations

4.

Chandy, Mark, Masayoshi Ishida, Eric A. Shikatani, et al.. (2018). c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells. PLoS ONE. 13(8). e0202778–e0202778. 10 indexed citations

5.

Elphinstone, Robyn E., Rickvinder Besla, Eric A. Shikatani, et al.. (2017). S-Nitrosoglutathione Reductase Deficiency Confers Improved Survival and Neurological Outcome in Experimental Cerebral Malaria. Infection and Immunity. 85(9). 14 indexed citations

6.

Adili, Reheman, M. Ahsan Siraj, Xiaohong Xu, et al.. (2016). Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis. Diabetes. 65(6). 1714–1723. 105 indexed citations

7.

Shikatani, Eric A., Mark Chandy, Rickvinder Besla, et al.. (2016). c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1 ⁺ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin. Arteriosclerosis Thrombosis and Vascular Biology. 36(7). 1367–1376. 24 indexed citations

8.

Shah, Anu, Ling Xia, Elodie Masson, et al.. (2015). Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy. Journal of the American Society of Nephrology. 26(12). 2963–2977. 90 indexed citations

9.

Robbins, Clinton S., Ingo Hilgendorf, Georg F. Weber, et al.. (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature Medicine. 19(9). 1166–1172. 779 indexed citations breakdown →

10.

Taniguchi, Kanta, Ling Xia, Howard Goldberg, et al.. (2013). Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice. Diabetes. 62(11). 3874–3886. 119 indexed citations

11.

Shikatani, Eric A., Emilie Roudier, Andrei-Alexandru Szigiato, et al.. (2012). Inhibition of Proliferation, Migration and Proteolysis Contribute to Corticosterone-Mediated Inhibition of Angiogenesis. PLoS ONE. 7(10). e46625–e46625. 43 indexed citations

12.

El-Mounayri, Omar, Anton Mihic, Eric A. Shikatani, et al.. (2012). Serum-free differentiation of functional human coronary-like vascular smooth muscle cells from embryonic stem cells. Cardiovascular Research. 98(1). 125–135. 26 indexed citations

13.

Noyan-Ashraf, M. Hossein, Eric A. Shikatani, Irmgard Schuiki, et al.. (2012). A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity. Circulation. 127(1). 74–85. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact